Work

Clinical Pharmacokinetic (PK) and Safety (Immunogenicity) of Rituximab Biosimilar RTXM83 in Combination with Chemotherapy CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.5472.5472

Authors: Amalia Florez, Thiago Di Matteo, Gloria Fresnillo, Consuelo Tudela, Mauricio Seigelchifer, Esteban Corley, Analia Pesce, Cedric Bes, Susana Millan

Institution: mAbxience Holding, S.L. (Spain)

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W417333223

FWCI: 0.549

Cites:

Cited by: 8

Related to: 10